The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what GHK Cu: The Peptide That Transforms Skin and Tissue Health Calibrate Hydration GHK Cu Peptide (50mg) Advanced Skin Rejuvenation & Healing Support FDA Peptide Reclassification 2026 Amanecia Health FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn GHK Cu Vici Peptides